Subcutaneous Biologics: The Unmet Requirement in the Pharmaceutical Space
Roots Analysis
MARCH 21, 2022
However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous biologics – current market landscape. Subcutaneous drug delivery systems – the helping hand for patients. Of these, 50 players have approved subcutaneous biologics.
52 
Let's personalize your content